Left Atrial Appendage Closure Devices Market
According to Intent Market Research, the Left Atrial Appendage Closure Devices Market is expected to grow from USD 2.6 Billion in 2024-e at a CAGR of 14.3% to touch USD 5.8 Billion by 2030. The Left Atrial Appendage Closure Devices Market is dominated by key players such as, Abbott Laboratories, Medtronic PLC, Johnson & Johnson, Boston Scientific Corporation, St. Jude Medical (Acquired by Abbott), and AtriCure, Inc..